This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Accenture Set to Report Q1 Earnings: Here's What You Should Know
by Zacks Equity Research
ACN's first-quarter fiscal 2025 top line is likely to have benefited from the SynOps platform to drive automation.
Here is What to Know Beyond Why Docusign Inc. (DOCU) is a Trending Stock
by Zacks Equity Research
DocuSign (DOCU) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Can DocuSign (DOCU) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
DocuSign (DOCU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
DocuSign (DOCU) Is Up 34.26% in One Week: What You Should Know
by Zacks Equity Research
Does DocuSign (DOCU) have what it takes to be a top stock pick for momentum investors? Let's find out.
DocuSign Shares Gain 22% After Posting Q3 Earnings & Revenue Beat
by Zacks Equity Research
DOCU's third-quarter fiscal 2025 top-line increases year over year due to improved segmental performance.
MDB's Shares Fall 16% Year to Date: How Should Investors Play the Stock?
by Zacks Equity Research
MongoDB is navigating macroeconomic challenges, with strong partnerships and AI-driven innovations aiding its prospects.
OSPN Shares Rise 72% Year to Date: Should Investors Buy the Stock?
by Zacks Equity Research
OneSpan is benefiting from strong subscription revenues and an improved product portfolio amid challenges in hardware sales.
DocuSign (DOCU) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for DocuSign (DOCU) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
DocuSign (DOCU) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
DocuSign (DOCU) delivered earnings and revenue surprises of 4.65% and 1.41%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy, Sell, or Hold Docusign Stock Before Q3 Earnings?
by Shuvra Shankar Dey
DOCU's third-quarter fiscal 2025 earnings and revenues are likely to increase year over year.
Unlocking Q3 Potential of DocuSign (DOCU): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for DocuSign (DOCU), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2024.
DocuSign (DOCU) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
DocuSign (DOCU) reachead $85.30 at the closing of the latest trading day, reflecting a -0.25% change compared to its last close.
Docusign Stock Rises 20% in a Month: Should You Hold or Fold?
by Shuvra Shankar Dey
With DOCU shares witnessing a substantial surge, it's crucial to evaluate the stock's current position and its investment appeal.
Docusign Inc. (DOCU) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching DocuSign (DOCU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Reasons Why You Should Bet on Trane Technologies Stock Now
by Zacks Equity Research
TT consistently rewards its shareholders through dividend payments and share repurchases.
DocuSign (DOCU) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
DocuSign (DOCU) concluded the recent trading session at $79.52, signifying a +1.47% move from its prior day's close.
AppFolio Rises 33% YTD: Should You Buy, Sell or Hold the Stock?
by Zacks Equity Research
APPF's strong market position, innovative products and robust financial prospects make the stock an attractive pick for investors.
Reasons Why You Should Hold DocuSign Stock in Your Portfolio
by Zacks Equity Research
DOCU is experiencing a rise in customer demand for eSignature and benefiting from adopting a subscription model.
DocuSign (DOCU) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the most recent trading session, DocuSign (DOCU) closed at $81.81, indicating a -0.8% shift from the previous trading day.
SurgePays, Inc. (SURG) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
SurgePays, Inc. (SURG) delivered earnings and revenue surprises of -231.82% and 44.79%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
BlackLine (BL) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
BlackLine (BL) delivered earnings and revenue surprises of 15.38% and 1.79%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
DocuSign (DOCU) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the most recent trading session, DocuSign (DOCU) closed at $76.47, indicating a +1.27% shift from the previous trading day.
Docusign Inc. (DOCU) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
DocuSign (DOCU) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CS Disco (LAW) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
CS Disco (LAW) delivered earnings and revenue surprises of 33.33% and 0.04%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
NYT Q3 Earnings Beat Estimates, Subscription Revenues Climb Y/Y
by Zacks Equity Research
The New York Times Company's Q3 results reflect a y/y increase in subscription revenues. Management expects Q4 subscription revenues to ascend 7-9%.